tranexamic acid has been researched along with Cyanosis in 5 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Cyanosis: A bluish or purplish discoloration of the skin and mucous membranes due to an increase in the amount of deoxygenated hemoglobin in the blood or a structural defect in the hemoglobin molecule.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Tranexamic acid has been used both topically and systemically and plays a vital role in pediatric cardiac surgery by reducing blood loss and blood product requirement." | 2.84 | Topical and low-dose intravenous tranexamic acid in cyanotic cardiac surgery. ( Deodhar, S; Gandhi, H; Pandya, H; Patel, H; Patel, J; Prajapati, M, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Patel, J | 1 |
| Prajapati, M | 1 |
| Patel, H | 1 |
| Gandhi, H | 1 |
| Deodhar, S | 1 |
| Pandya, H | 1 |
| Shimizu, K | 1 |
| Toda, Y | 1 |
| Iwasaki, T | 1 |
| Takeuchi, M | 1 |
| Morimatsu, H | 1 |
| Egi, M | 1 |
| Suemori, T | 1 |
| Suzuki, S | 1 |
| Morita, K | 1 |
| Sano, S | 1 |
| Bulutcu, FS | 1 |
| Ozbek, U | 1 |
| Polat, B | 1 |
| Yalçin, Y | 1 |
| Karaci, AR | 1 |
| Bayindir, O | 1 |
| Zonis, Z | 1 |
| Seear, M | 2 |
| Reichert, C | 1 |
| Sett, S | 2 |
| Allen, C | 1 |
| Levin, E | 1 |
| Wu, J | 1 |
| Devine, DV | 1 |
| Alexander, J | 1 |
| Reichart, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prophylactic Use of Tranexamic Acid for Preventing Postpartum Hemorrhage: A Randomized, Double-blinded, Placebo-controlled Pilot Trial[NCT03069859] | Phase 2 | 31 participants (Actual) | Interventional | 2018-03-06 | Active, not recruiting | ||
| Tranexamic Acid Reduces Blood Loss in Pediatric Cardiac Surgery[NCT00994994] | 160 participants (Actual) | Interventional | 2006-01-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 trials available for tranexamic acid and Cyanosis
| Article | Year |
|---|---|
Topical and low-dose intravenous tranexamic acid in cyanotic cardiac surgery.
Topics: Administration, Intravenous; Administration, Topical; Adolescent; Antifibrinolytic Agents; Blood Coa | 2017 |
Effect of tranexamic acid on blood loss in pediatric cardiac surgery: a randomized trial.
Topics: Adolescent; Blood Loss, Surgical; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Child; Child, | 2011 |
Effect of tranexamic acid on blood loss in pediatric cardiac surgery: a randomized trial.
Topics: Adolescent; Blood Loss, Surgical; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Child; Child, | 2011 |
Effect of tranexamic acid on blood loss in pediatric cardiac surgery: a randomized trial.
Topics: Adolescent; Blood Loss, Surgical; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Child; Child, | 2011 |
Effect of tranexamic acid on blood loss in pediatric cardiac surgery: a randomized trial.
Topics: Adolescent; Blood Loss, Surgical; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Child; Child, | 2011 |
Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination?
Topics: Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Cardiac Surgical Procedures; Child; Cyanos | 2005 |
The effect of preoperative tranexamic acid on blood loss after cardiac operations in children.
Topics: Adolescent; Antifibrinolytic Agents; Blood Loss, Surgical; Cardiopulmonary Bypass; Child; Child, Pre | 1996 |
Hemostatic parameters and platelet activation marker expression in cyanotic and acyanotic pediatric patients undergoing cardiac surgery in the presence of tranexamic acid.
Topics: Antifibrinolytic Agents; Child; Child, Preschool; Coronary Artery Bypass; Cyanosis; Female; Heart De | 2000 |